ArticleCancer research2010

Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway.

Margaret A Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.